Collaborations
Business Development Calendar
 
About UsPipelineTechnologyPartneringInvestor RelationsCareers
 
   
 
Collaborations

As part of its business strategy, Micromet is collaborating with industry partners on the development of certain product candidates and the expansion of its development pipeline.

Partner

Area of collaboration

Press Release

sanofi-aventis

Global collaboration to develop a BiTE antibody against an undisclosed solid tumor target

more

Bayer Schering

Exclusive option to license a BiTE antibody against an undisclosed solid tumor target

more

Nycomed

Collaboration on development of anti-inflammatory antibody MT203

more

Merck Serono

Collaboration on development and commercialization of the anti-cancer antibody adecatumumab (MT201)

more

MedImmune

Co-development of Micromet’s BiTE® antibody MT111 (MEDI-565)

more

 
   
ContactDirectionsEmail Alert 
HomeImprintLegal Notices